Beta-blockers in patients with advanced liver disease: Has the dust settled?-Reference-Cited by-同舟云学术

Beta-blockers in patients with advanced liver disease: Has the dust settled?

Published:2017-07-03 Issue:8 Volume:23 Page:1058-1069
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Moctezuma-Velazquez Carlos¹,Kalainy Sylvia¹,Abraldes Juan G.¹

Affiliation:

1. Cirrhosis Care Clinic, Liver Unit, Division of Gastroenterology, Centre of Excellence for Gastrointestinal Inflammation and Immunity Research; University of Alberta; Edmonton Canada

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Reference60 articles.

1. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension;Franchis;J Hepatol,2015

2. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites;Sersté;Hepatology,2010

3. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis and management: 2016 practice guidance by the American Association for the study of liver diseases;Garcia-Tsao;Hepatology,2017

4. Evolution in the understanding of the pathophysiological basis of portal hypertension: how changes in paradigm are leading to successful new treatments;Bosch;J Hepatol,2015

5. Risk of bacterial infection in patients with cirrhosis and acute variceal hemorrhage, based on Child-Pugh class, and effects of antibiotics;Tandon;Clin Gastroenterol Hepatol,2015

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of midodrine on HVPG in advanced chronic liver disease and acute‐on‐chronic liver failure—A pilot study;Liver International;2024-07-24

2. The effect of propranolol on gastrointestinal motility and permeability in patients with cirrhosis and significant portal hypertension;2024-03-29

3. Hepatorenal Syndrome—Novel Insights into Diagnostics and Treatment;International Journal of Molecular Sciences;2023-12-14

4. The evolution of available pharmacological treatments for variceal bleeding secondary to portal hypertension: A scope review;iLIVER;2023-09

5. Management of Portal Hypertension in Patients with Acute-on-Chronic Liver Disease;Clinics in Liver Disease;2023-08